Trial
NCT02472938
Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
GB Pharma Services & Consulting s.r.l.
Condition
Relapsing Remitting Multiple Sclerosis
Intervention
dimethyl fumarate
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-28